| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
|
Clin Cancer Res
|
2000
|
1.60
|
|
2
|
Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB).
|
Urol Int
|
2000
|
1.24
|
|
3
|
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance.
|
Lab Invest
|
1999
|
1.10
|
|
4
|
Clear cell sarcoma of the kidney with invasion of the inferior vena cava.
|
Urol Int
|
2003
|
1.07
|
|
5
|
Immunohistochemical detection of estrogen and progesterone receptors in the normal urinary bladder and in pseudomembranous trigonitis.
|
J Endocrinol Invest
|
1992
|
1.04
|
|
6
|
Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
|
Eur Urol
|
2000
|
0.89
|
|
7
|
White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study.
|
Cancer Epidemiol Biomarkers Prev
|
1998
|
0.88
|
|
8
|
Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer.
|
Br J Cancer
|
2004
|
0.81
|
|
9
|
The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome.
|
Urol Int
|
2014
|
0.79
|
|
10
|
[Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma].
|
Minerva Urol Nefrol
|
1990
|
0.79
|
|
11
|
Wheat bran in the selective therapy of absorptive hypercalciuria: a study performed on 18 lithiasic patients.
|
J Urol
|
1989
|
0.77
|
|
12
|
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.
|
Clin Chim Acta
|
2001
|
0.76
|
|
13
|
Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal.
|
Scand J Urol Nephrol
|
1998
|
0.76
|
|
14
|
Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise.
|
Cancer Lett
|
1994
|
0.76
|
|
15
|
Prostatic duct carcinoma with combined prostatic duct adenocarcinoma and urothelial carcinoma features: report of a case.
|
Int J Surg Pathol
|
2004
|
0.76
|
|
16
|
[Surgical treatment of benign prostatic hypertrophy and Kelami syndrome].
|
Minerva Urol Nefrol
|
1995
|
0.75
|
|
17
|
[Formation of calculi as a complication of a double-J ureteral endoprosthesis. Presentation of 2 cases].
|
Minerva Urol Nefrol
|
1987
|
0.75
|
|
18
|
[Contribution to the study of phospho-calcium metabolism in the immobilized patient].
|
Minerva Urol Nefrol
|
1987
|
0.75
|
|
19
|
[Incrusted cystitis. Etiopathogenesis and discussion of l0 new cases].
|
Minerva Urol Nefrol
|
1985
|
0.75
|
|
20
|
Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
|
Prog Clin Biol Res
|
1991
|
0.75
|
|
21
|
[The Sarig test. A simple method to evaluate the inhibitory effect on urinary crystallization of calcium oxalate].
|
Minerva Urol Nefrol
|
1992
|
0.75
|
|
22
|
Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events.
|
Hum Pathol
|
2001
|
0.75
|
|
23
|
Detection of estrogen receptors in the trigonum and urinary bladder with an immunohistochemical technique.
|
Gynecol Endocrinol
|
1990
|
0.75
|
|
24
|
[Aztreonam in complicated infections of the urinary tract].
|
Minerva Urol Nefrol
|
1987
|
0.75
|
|
25
|
[The computer in urodynamics].
|
Minerva Urol Nefrol
|
1988
|
0.75
|
|
26
|
[Adenocarcinoma of the scrotum: a case report].
|
Minerva Urol Nefrol
|
2006
|
0.75
|
|
27
|
[Use of a urease inhibitor, propionohydroxamic acid, in the treatment and prevention of infectious renal lithiasis. A study of 19 patients].
|
Minerva Urol Nefrol
|
1987
|
0.75
|
|
28
|
[Use of cefoxitin in urology].
|
Minerva Urol Nefrol
|
1985
|
0.75
|
|
29
|
[Dietary food fiber supplements in the treatment of absorptive calciuria].
|
Minerva Urol Nefrol
|
1988
|
0.75
|
|
30
|
[Silica urolithiasis. Review of the literature and presentation of a new case].
|
Minerva Urol Nefrol
|
1986
|
0.75
|
|
31
|
[An in vitro antiblastic drug sensitivity test in bladder carcinoma. Preliminary research].
|
Minerva Urol Nefrol
|
1986
|
0.75
|
|
32
|
[Therapy with cefoperazone in complicated infections of the urinary tract].
|
Minerva Urol Nefrol
|
1988
|
0.75
|
|
33
|
[A new method for treating benign prostatic hypertrophy: transurethral prostatic vaporization].
|
Minerva Urol Nefrol
|
1995
|
0.75
|
|
34
|
Magnesium excretion in recurrent calcium urolithiasis. Evaluation of 46 hypercalciuric patients.
|
Contrib Nephrol
|
1987
|
0.75
|
|
35
|
[Screening for prostate cancer: reasons for, reasons against].
|
Minerva Urol Nefrol
|
1999
|
0.75
|
|
36
|
[Comparison of fluoroquinolones (norfloxacin, enoxacin, ofloxacin) in the therapy of lower urinary tract infections].
|
Minerva Urol Nefrol
|
1990
|
0.75
|
|
37
|
Propionohydroxamic acid in the treatment of urease-induced calculi. Six months follow-up of 19 patients.
|
Contrib Nephrol
|
1987
|
0.75
|
|
38
|
[The use of hemorrhage occluder pins in radical pelvic urologic surgery].
|
Minerva Urol Nefrol
|
1993
|
0.75
|
|
39
|
[Erection deficit in patients subjected to a radical cystectomy. Diagnostic evaluation by Doppler and sacral evoked reflexes].
|
Minerva Urol Nefrol
|
1986
|
0.75
|
|
40
|
CA-50 as tumour marker in transitional bladder carcinoma.
|
Br J Urol
|
1989
|
0.75
|
|
41
|
Serum prostate-specific antigen determination in prostatic carcinoma.
|
Int J Biol Markers
|
1988
|
0.75
|
|
42
|
Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer.
|
Carcinogenesis
|
1997
|
0.75
|
|
43
|
[Comparative therapeutic evaluation of 2 quinolone derivatives, norfloxacin and cinoxacin, in complicated infections of the urinary tract].
|
Minerva Urol Nefrol
|
1986
|
0.75
|
|
44
|
[A case of complicated giant urethro-vesical calculosis. Etiopathogenetic considerations].
|
Minerva Urol Nefrol
|
1986
|
0.75
|
|
45
|
Recurrent calcium oxalate urolithiasis in a man with familial periodic paralysis and hypokalemia.
|
J Urol
|
1999
|
0.75
|
|
46
|
Incidence of urinary tract infections following endoscopic surgery in immunodepressed patients treated with thymostimulin.
|
J Exp Pathol
|
1987
|
0.75
|
|
47
|
[Leiomyosarcoma of the spermatic cord. Case report and revision of the literature].
|
Minerva Urol Nefrol
|
1994
|
0.75
|
|
48
|
[A case of retroperitoneal leiomyosarcoma].
|
Minerva Urol Nefrol
|
1992
|
0.75
|
|
49
|
DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
|
Minerva Urol Nefrol
|
1997
|
0.75
|
|
50
|
[Urinary excretion of magnesium in recurrent calcic nephrolithiasis. Evaluation on different dietary regimens].
|
Minerva Urol Nefrol
|
1987
|
0.75
|
|
51
|
Urinary evaluation of tumor-associated antigens in bladder urothelium pathologies.
|
J Nucl Med Allied Sci
|
1991
|
0.75
|
|
52
|
Carbohydrate antigen 19-9 immunohistochemistry in transitional bladder carcinoma.
|
J Nucl Med Allied Sci
|
1991
|
0.75
|
|
53
|
Low dosage treatment with propiono-hydroxamic acid in paraplegic patients.
|
Eur Urol
|
1989
|
0.75
|
|
54
|
Effect of inhibitors on the crystal growth of calcium oxalate.
|
Contrib Nephrol
|
1987
|
0.75
|